- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
PharmaEssentia USA announced the appointment of Beth Krewson as head of legal.
Prior to this, Krewson served as the first in-house general counsel at Formation Bio. Before that, she was the senior vice president, general counsel and compliance officer at BlueRock Therapeutics LP.
Previously, she held general counsel and chief compliance officer positions at Innocoll Biotherapeutics N.A. and Churchill Pharmaceuticals.
Compliance Week accepts outside contributions from corporate chief compliance officers and other senior-level GRC practitioners. To learn more, contact the CW Editor.
President-elect Donald Trump announced he plans to appoint Cantor Fitzgerald President and CEO Howard Lutnick to lead the U.S. Commerce Department, as the incoming administration is expected to charge import tariffs against friends and foes.
A publicly traded cryptocurrency mining company will pay $10 million and completely change its business model to one with “lower corruption risk” as part of a settlement over violations of the Foreign Corrupt Practices Act (FCPA), two regulators announced.
Commercial real estate finance and advisory services firm Walker & Dunlop announced that Dan Groman will be its executive vice president, general counsel, secretary and chief compliance officer.
No comments yet